Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2015-02-12 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
未来三年（2015-2017年）股东回报规划
Notice of Dividend Amount Classification · 90% confidence The document is a detailed plan outlining the company's shareholder return policy for the years 2015-2017. It discusses principles, specific dividend distribution methods, decision-making procedures, and mechanisms related to shareholder returns. It is not a financial report, earnings release, or regulatory filing but rather a formal policy document issued by the company's board. The content focuses on dividend policy and shareholder return planning rather than announcing dividend amounts or results. Therefore, it fits best under the category of Notice of Dividend Amount (DIV) as it relates to dividend distribution plans and policies.
2015-02-12 Chinese
截至2014年9月30日止的前次募集资金使用情况报告
Capital/Financing Update Classification · 95% confidence The document is titled as a report on the usage of previously raised funds by 嘉事堂药业股份有限公司 as of September 30, 2014. It details the amount of funds raised, their allocation, usage status, changes in investment projects, economic benefits realized from the investments, and compliance with disclosure requirements. The document includes audited confirmations and approvals by the board. The content focuses specifically on the use of capital raised from a prior stock issuance, including detailed financial figures and project updates. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital usage. The document is not a full annual or interim report, nor is it an announcement or certification only. Therefore, the appropriate classification is CAP with high confidence.
2015-02-12 Chinese
独立董事关于第四届董事会第二十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of 嘉事堂药业股份有限公司 regarding matters discussed at the company's fourth board of directors' 20th meeting. It specifically addresses the non-public issuance of shares and the formulation of a three-year shareholder return plan. The document references compliance with regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and it concludes with the independent directors' agreement to submit these matters to the shareholders' meeting for approval. The content is focused on governance and board-level opinions rather than financial results, audit findings, or regulatory filings. It is not a full annual or interim report, nor is it a simple announcement or certification. The document fits best under Board/Management Information (MANG) as it relates to board opinions on corporate actions and governance matters.
2015-02-12 Chinese
关于第四届监事会第十三次会议决议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement of resolutions passed at the 13th meeting of the 4th Supervisory Board of 嘉事堂药业股份有限公司 on February 12, 2015. It details decisions related to terminating a convertible bond issuance plan and changing the refinancing method to a non-public stock issuance, including specifics about the stock issuance plan, pricing, lock-up period, and use of proceeds. The document also mentions that these proposals will be submitted to the shareholders' meeting for approval. The content is primarily about financing activities and capital structure changes, specifically a non-public stock issuance. It is not a full financial report but an announcement of financing plans and related board resolutions. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (5848 characters) and detailed content support this classification rather than a brief announcement or a regulatory filing.
2015-02-12 Chinese
关于召开2015年第一次临时股东大会的通知公告
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2015 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed (such as non-public stock issuance plans), shareholder eligibility, registration methods, and proxy voting instructions. The document does not contain financial statements or results but is an announcement and procedural guide for the shareholders' meeting. It is not a report of voting results, nor is it a proxy solicitation or remuneration report. Given the detailed nature of the meeting notice and voting instructions, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting. The document length (6515 characters) and content confirm it is the meeting notice itself, not just an announcement of a report or a brief summary. Therefore, the correct classification is AGM Information (AGM-R).
2015-02-12 Chinese
关于股东减持股份的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement from 嘉事堂药业股份有限公司 regarding a shareholder, 上海张江高科技园区开发股份有限公司, reducing its shareholding from above 5% to below 5%. It details the number of shares sold, dates, prices, and confirms compliance with relevant regulations. The document is short (1424 characters) and focuses on a change in major shareholding levels rather than financial results or management changes. It matches the definition of a Major Shareholding Notification (MRQ).
2015-01-23 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.